Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Nov;24(5):417-22.
doi: 10.1053/ejvs.2002.1754.

Role of subintimal angioplasty in the treatment of chronic lower limb ischaemia

Affiliations
Free article

Role of subintimal angioplasty in the treatment of chronic lower limb ischaemia

P V Tisi et al. Eur J Vasc Endovasc Surg. 2002 Nov.
Free article

Abstract

Objectives: To determine the clinical outcome of subintimal angioplasty (SA) and to assess impact on surgical workload.

Design: Retrospective review of a single radiologist's case series.

Materials: One hundred and twenty two patients with critical limb ischaemia and 26 with claudication.

Methods: One hundred and fifty eight limbs treated by SA.

Main outcome measures: Technical success and complications; cumulative patency, limb salvage and survival; affect of SA on vascular workload.

Results: The technical success rate was 85%. There were 26 procedural complications (16%) but no patient required emergency surgery; 30-day mortality was 3%. Primary and secondary 12-month patency rates were 27 and 33%. Limb salvage rate was 88% at 12 months. SA initially reduced the number of patients needing arterial surgery, although this then increased due to late failure of SA and an increase in de novo bypass.

Conclusions: SA carries a low risk of major complications and high immediate technical success. Poor long-term patency suggests that SA is not as durable as bypass surgery. However, failed SA did not compromise subsequent surgery, which only became necessary in a proportion of patients. Our data suggests that there is little to be lost by using SA as first-line treatment for patients with limb-threatening ischaemia who are poor operative risks or who have no autologous vein available.

PubMed Disclaimer

LinkOut - more resources